Circulating inflammatory biomarkers, adipokines and breast cancer risk—a case-control study nested within the EPIC cohort

Manon Cairat(Centre international de recherche sur le cancer), Laure Dossus(St. Elizabeth's Hospital), Pilar Amiano Etxezarreta(Basque Government), Carine Biessy, Evelyn M. Monninkhof(University Medical Center Utrecht), Krasimira Aleksandrova(German Institute of Human Nutrition), Sabina Rinaldi(St. Elizabeth's Hospital), Anouk E. Hiensch(Utrecht University), Antonio Agudo(Institut Català d'Oncologia), Ruth C. Travis, Rudolf Kaaks(German Cancer Research Center), Matthias B. Schulze(German Institute of Human Nutrition), Amalia Mattiello(University of Naples Federico II), A. Fournier(Inserm), ­Rosario ­Tumino(Azienda Usl 8 Arezzo), Sabina Sieri(St. Elizabeth's Hospital), Chiara Grasso(University of Turin), Giovanna Masala(Piedmont Reference Center for Epidemiology and Cancer Prevention), Inger Torhild Gram(St. Elizabeth's Hospital), Renée T. Fortner(Heidelberg University), Vivian Viallon(Centre international de recherche sur le cancer), Marina Kvaskoff(Université Paris-Sud), Aurelio Barricarte(Instituto de Salud Pública de Navarra), Marc J. Gunter(Harvard University), Anne‐Sophie Navionis(Centre international de recherche sur le cancer), David C. Muller(Centre National de la Recherche Scientifique), Anja Olsen(Danish Cancer Society), Elisabete Weiderpass(St. Elizabeth's Hospital), Anne Tjønneland(St. Elizabeth's Hospital), Gianluca Severi(Inserm), María‐José Sánchez(Universidad de Granada), Karina Standahl Olsen(UiT The Arctic University of Norway), Carmen Santiuste(Instituto Murciano de Investigación Biosanitaria), Isabelle Romieu(Johns Hopkins University), Melissa A. Merritt(Imperial College London)
BMC Medicine
April 18, 2022
Cited by 27


Related Papers